focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMPM.L Regulatory News (MPM)

  • There is currently no data for MPM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of General Meeting & Directors Holdings

10 Oct 2014 11:22

RNS Number : 0029U
MoPowered Group PLC
10 October 2014
 



 

MOPOWERED GROUP PLC

 

("MoPowered" or the "Company")

 

Result of General Meeting

and

Directors' Holdings

 

On 22 September 2014 MoPowered Group Plc (MPOW), the mobile commerce specialist, announced that it had conditionally raised £3.5 million (before expenses) through the issue of 70,000,000 ordinary shares of 0.5 pence each ("Ordinary Shares") at a price of 5 pence per new Ordinary Share (the "Placing"). The Company made a further announcement on 7 October 2014 that it had conditionally raised an additional £157,000 through the issue of 3,140,000 Ordinary Shares at a price of 5 pence per new Ordinary Share (the "Second Placing") in connection with the purchase from Rounded Labs Limited of the Cortana platform, an app-creation software asset which allows for the rapid construction of mobile commerce applications. Both the Placing and the Second Placing are conditional, amongst other things, on the Resolutions being passed.

 

The Company is pleased to announce that at the General Meeting held earlier today all Resolutions proposed were duly passed.

 

Application has been made to the London Stock Exchange for the 73,140,000 new Ordinary Shares conditionally placed pursuant to the Placing and the Second Placing to be admitted to trading on AIM ("Admission"). It is expected that Admission will become effective on or around 13 October 2014.

 

Following Admission, the number of Ordinary Shares that the Company will have in issue will be 89,052,803. The total number of voting rights of the Company will be 89,052,803. This figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company.

 

The Directors of the Company hold and will, immediately following Admission, hold the following interests in the issued share capital of the Company.

 

Number of Ordinary Shares in the Company

Percentage of Existing Share Capital

Number of Ordinary Shares immediately following Admission

Percentage of Enlarged Share Capital following Admission

Dominic Keen

3,391,903*

21.32%*

15,391,903**

17.28%**

Richard Mann

55,000

0.34%

55,000

0.06%

Mike Hughes

20,000

0.13%

20,000

0.02%

 

* of these Ordinary Shares, 587,500 Ordinary Shares are held by Dominic Keen and his spouse, 2,485,440 Ordinary Shares are held by the Trustees of the Imperialise Limited Pension Fund of which Dominic Keen is a member and 318,963 Ordinary Shares are held by Imperialise Limited of which Dominic Keen is a shareholder.

 

** of these Ordinary Shares, 587,500 Ordinary Shares are held by Dominic Keen and his spouse, 4,485,440 Ordinary Shares are held by the Trustees of the Imperialise Limited Pension Fund of which Dominic Keen is a member, 318,963 Ordinary Shares are held by Imperialise Limited of which Dominic Keen is a shareholder and 10,000,000 Ordinary Shares are held by Twocan Limited, a company owned by a trust of which Dominic Keen is a beneficiary.

 

 

Defined terms used in this announcement shall have the same meaning as those terms defined and used in the circular of the Company dated 22 September 2014.

 

MoPowered:

020 3242 0515

Dominic Keen, Chief Executive Officer

Mike Hughes, Chairman

 

N+1 Singer:

 

020 7496 3000

 

Shaun Dobson

Gillian Martin

Emily Watts

 

 

 

Buchanan:

 

020 7466 5000

 

Charles Ryland

 

Sophie McNulty

 

Clare Akhurst

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFFSFSSFLSEES
Date   Source Headline
27th Jun 20087:00 amRNSAHS Meeting
25th Jun 200810:28 amRNSDirector/PDMR Shareholding
24th Jun 200810:23 amRNSResult of Annual General Meet
24th Jun 20087:00 amRNSAGM Statement
16th Jun 20087:30 amRNSTEMPUS study fully enrolled
4th Jun 20087:00 amRNSAnnual Report and Accounts
2nd Jun 20087:00 amRNSUS Marketing Consultant
22nd May 20087:00 amRNSPreliminary Results
12th Mar 20087:00 amRNSAura trial fully enrolled
5th Feb 20087:00 amRNSTEMPUS Trial Update
3rd Dec 20077:00 amRNSInterim Results
16th Oct 20077:00 amRNSTEMPUS trial starts in US
4th Oct 200711:06 amRNSChange of Registered Office
28th Sep 200711:32 amRNSDirector/PDMR Shareholding
17th Aug 20077:00 amRNSAIM Rule 26
16th Jul 200711:29 amRNSResult of AGM
16th Jul 20077:00 amRNSAGM Statement
2nd Jul 20074:13 pmRNSHolding(s) in Company
27th Jun 20077:01 amRNSIHS Scientific Meeting
21st Jun 20075:05 pmRNSAnnual Report and Accounts
13th Jun 20077:02 amRNSPreliminary Results
7th Jun 20077:02 amRNSAHS Scientific Meeting
1st Jun 20078:30 amRNSTotal Voting Rights
18th May 20079:20 amRNSAdditional Listing
30th Apr 20076:22 pmRNSHolding(s) in Company
30th Apr 200712:16 pmRNSTotal Voting Rights
11th Apr 20074:39 pmRNSConversion of Loan Note
2nd Apr 20073:27 pmRNSHolding(s) in Company
2nd Apr 20072:55 pmRNSHolding(s) in Company
2nd Apr 20071:26 pmRNSDirector/PDMR Shareholding
30th Mar 20079:32 amRNSTotal Voting Rights
27th Mar 20077:01 amRNSBoard Appointments
26th Mar 200710:31 amRNSResult of EGM
2nd Mar 20077:30 amRNSGPB17m fundraising
9th Jan 20077:01 amRNSPositive Tonabersat Study
20th Dec 20065:43 pmRNSTotal Voting Rights
1st Dec 20067:01 amRNSInterim Results
17th Nov 20067:01 amRNSPlacing
25th Oct 200610:20 amRNSResult of AGM
25th Oct 20067:01 amRNSAGM Statement
27th Sep 20067:00 amRNSNIH Collaboration
20th Sep 20067:02 amRNSPreliminary Results
7th Sep 20067:00 amRNSAdditional Indications
15th Aug 200611:37 amRNSNotification of Interests
20th Jun 20067:00 amRNSStart of Phase II Trial
24th May 20067:01 amRNSUCLA Collaboration
21st Mar 20067:00 amRNSStart of Phase II Trial
8th Mar 20067:03 amRNSChange of Adviser
13th Jan 20067:00 amPRNRe Agreement
8th Dec 20057:00 amPRNInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.